Erica Smit

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

Angelique Kany Kany Luabeya, Benjamin M. Kagina, Michèle Tameris et al. · Vaccine · 2015 · 190 citations

Vaccination, Pulmonary Tuberculosis, Tuberculosis Prevention +11

Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4⁺ T cells

Thomas J. Scriba, Michèle Tameris, Nazma Mansoor et al. · European Journal of Immunology · 2009 · 189 citations · Full text

Immunology, Immunodominance, Immunologic Mechanism +22

Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis

Albanus O. Moguche, Munyaradzi Musvosvi, Adam Penn‐Nicholson et al. · Cell Host & Microbe · 2017 · 180 citations · Full text

Pulmonary Tuberculosis, Adaptive Immune System, T-regulatory Cell +8

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa

Tony Hawkridge, Thomas J. Scriba, Sebastian Gelderbloem et al. · The Journal of Infectious Diseases · 2008 · 169 citations · Full text

Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial

Adam Penn‐Nicholson, Michèle Tameris, Erica Smit et al. · The Lancet Respiratory Medicine · 2018 · 146 citations

Vaccination, Vaccine Safety, Pulmonary Tuberculosis +11